Arcutis Biotherapeutics, Inc. (ARQT): R&D Expense
$77.05M
Year ended 2025-12-31
$91.04M
Trailing 12 months to 2026-06-30
-25.0%
3-year compound annual growth
-7.7%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $77.05M | +0.8% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $76.42M | -30.9% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $110.58M | -39.4% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $182.44M | +25.3% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $145.56M | +26.2% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $115.31M | +215.7% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $36.52M | +103.6% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $17.94M | n/a | 2021-02-16, From 2018-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $77.05M | +0.8% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $216.18M | -20.1% |
| MannKind Corp (MNKD) | 2025-12-31 | $66.35M | +44.6% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $71.53M | +36.7% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $30.60M | +124.1% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $19.33M | +390.4% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $220.90M | -5.8% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $9.58M | +4.4% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $95.14M | -14.6% |
Compare ARQT, SVA, MNKD, ARDX side by side · Screen every company in Pharmaceutical Preparations ↗